Invention Grant
- Patent Title: Hybrid polypeptides having glucose lowering activity
- Patent Title (中): 具有葡萄糖降低活性的杂交多肽
-
Application No.: US11206903Application Date: 2005-08-17
-
Publication No.: US08076288B2Publication Date: 2011-12-13
- Inventor: Odile Esther Levy , Michael R. Hanley , Carolyn M. Jodka , Diana Y. Lewis , Christopher J. Soares , Soumitra S. Ghosh , Lawrence J. D'Souza , David G. Parkes , Christine M. Mack
- Applicant: Odile Esther Levy , Michael R. Hanley , Carolyn M. Jodka , Diana Y. Lewis , Christopher J. Soares , Soumitra S. Ghosh , Lawrence J. D'Souza , David G. Parkes , Christine M. Mack
- Applicant Address: US CA San Diego
- Assignee: Amylin Pharmaceuticals, Inc.
- Current Assignee: Amylin Pharmaceuticals, Inc.
- Current Assignee Address: US CA San Diego
- Main IPC: A61K38/00
- IPC: A61K38/00 ; A61K38/26
Abstract:
The present invention relates generally to novel, selectable hybrid polypeptides useful as agents for the treatment and prevention of metabolic diseases and disorders which can be alleviated by control plasma glucose levels, insulin levels, and/or insulin secretion, such as diabetes and diabetes-related conditions. Such conditions and disorders include, but are not limited to, hypertension, dyslipidemia, cardiovascular disease, eating disorders, insulin-resistance, obesity, and diabetes mellitus of any kind, including type 1, type 2, and gestational diabetes.
Public/Granted literature
- US20060293232A1 Hybrid polypeptides with selectable properties Public/Granted day:2006-12-28
Information query
IPC分类:
